Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Dacarbazine × 90 days × Clear all

Sponsor

Conditions

Hodgkin Disease 5 Melanoma 3 Sarcoma 2 Uveal Melanoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Neoplasms 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leiomyosarcoma 1 Immunotherapy 1 Hyperthermia 1 Advanced Melanoma 1

Interventions

Dexamethasone 15 Cyclophosphamide 12 pembrolizumab 11 Rituximab 11 venetoclax 10 pomalidomide 10 fludarabine 9 Lenalidomide 8 Calcium Dobesilate 7 glofitamab 6 Gemcitabine 6 Cytarabine 6 carfilzomib 5 Temozolomide 5 Nivolumab 5 Etoposide 5 Bevacizumab 5 selinexor 4 ruxolitinib 4 obinutuzumab 4 daratumumab 4 Doxorubicin 4 Carboplatin 4 Capecitabine 4 Bortezomib 4 Azacitidine 4 zanubrutinib 3 tisagenlecleucel 3 elotuzumab 3 blinatumomab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡